INTERNATIONAL PATENT: WENZHOU WEIYI KANGZE BIOTECHNOLOGY CO., LTD., 温州玮祎康泽生物科技有限公司 FILES APPLICATION FOR "XIAP E3 LIGASE AS TARGET FOR TUMOR TREATMENT AND USE OF TARGETED COMPOUND THEREOF"

Posted On: 2025-12-21

GENEVA, Dec. 21 -- WENZHOU WEIYI KANGZE BIOTECHNOLOGY CO., LTD. (Room 7027, 7th Floor, Building 5, Chuangxin Chuangye Xintiandi, 999 Jinshi Road, Yongzhong Street, Longwan DistrictWenzhou, Zhejiang 325000), 温州玮祎康泽生物科技有限公司 (中国浙江省温州市龙湾区永中街道金石路999号创新创业新天地5号楼7楼7027室) filed a patent application (PCT/CN2025/100031) for "XIAP E3 LIGASE AS TARGET FOR TUMOR TREATMENT AND USE OF TARGETED COMPOUND THEREOF" on Jun 10, 2025. With publication no. WO/20...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: WENZHOU WEIYI KANGZE BIOTECHNOLOGY CO., LTD., 温州玮祎康泽生物科技有限公司 FILES APPLICATION FOR "XIAP E3 LIGASE AS TARGET FOR TUMOR TREATMENT AND USE OF TARGETED COMPOUND THEREOF"